Acute Vaginal Infection: BGY-1601-VT Tablet

We are studying a new vaginal tablet for women with acute vaginal infections to see if it works better than a placebo. The trial will help us understand its safety and effectiveness for conditions like Bacterial Vaginosis and Vulvovaginal Candidiasis.

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Who can participate in the clinical trial?

These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..

What medicines are being studied?

Medicines that are officially approved for use in the European Union and considered safe by EMA. These medicines are already on the market and may be tested for new conditions or populations.

Liv.52
Liv.52 is an herbal medicine used to support liver health and improve digestion and appetite.

What active substances are being studied?

Active substances that are officially approved for use in the European Union and considered safe by EMA. These substances are already on the market and may be tested for new conditions or populations.

Achillea Millefolium Seed
Achillea millefolium seed is a plant-derived substance traditionally used to help soothe minor skin irritation and support wound healing.
Capparis Spinosa Cortex
Capparis spinosa cortex is a plant-derived substance traditionally used to support liver function and ease digestive complaints.
Chicory Root
Chicory root is a natural source of fiber that supports digestive health by promoting beneficial gut bacteria and regular bowel movements.

What experimental substances are being tested?

Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.

Bgy-1601-Vt

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...
Cabinet du Dr Thierry KELLER
Obstetric gynecology
Colmar, France
Centre Hospitalier Universitaire Amiens Picardie
Obstetric gynecology
Colomiers, France
Centre Hospitalier Intercommunal De Castres Mazamet
Obstetric gynecology
Labruguière, France

Sponsor: Nexbiome Therapeutics
Last updated: Nov 27, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.